In human mammary adenocarcinomas, RANK protein expression, detected by immunohistochemistry (IHC), is found in 15-20% of estrogen receptor (ER)-positive tumors and in 40% of ER-negative breast adenocarcinomas. This evidence concerns the gene TNFRSF11A and breast adenocarcinoma.